Prostatis Group Portfolio holdings
Top Buys
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$27.8M |
| 2 |
Amplify CWP Enhanced Dividend Income ETF
DIVO
|
+$6.1M |
| 3 |
HDV
iShares Core High Dividend ETF
HDV
|
+$5.91M |
| 4 |
Vanguard Information Technology ETF
VGT
|
+$640K |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$337K |
Top Sells
| 1 |
Vanguard Growth ETF
VUG
|
+$16.1M |
| 2 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$7.23M |
| 3 |
FT Vest Fund of Deep Buffer ETFs
BUFD
|
+$4.58M |
| 4 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$4.47M |
| 5 |
iShares ESG Optimized MSCI USA ETF
SUSA
|
+$4.41M |
Sector Composition
| 1 | Healthcare | 4.6% |
| 2 | Technology | 4.03% |
| 3 | Consumer Discretionary | 2.65% |
| 4 | Financials | 1.9% |
| 5 | Industrials | 1.57% |
Similar funds
Prostatis Group's Q2 2022 Portfolio in Review
As of Q2 2022, Prostatis Group held 91 positions worth $64.2M, down 49% from $125M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Prostatis Group withdrew a net $55.8M in Q2 2022, closing 44 positions and reducing 18 holdings. Its most notable exit was Vanguard Growth ETF, an estimated $16.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 4.6% of assets, up from 4.4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Prostatis Group opened a new position in First Trust Enhanced Short Maturity ETF worth $27.7M.
- Prostatis Group's largest Q2 2022 buy was First Trust Enhanced Short Maturity ETF: 466,641 shares worth $27.7M.
- Prostatis Group added most to Amplify CWP Enhanced Dividend Income ETF in Q2 2022, an estimated $6.1M increase.
- Prostatis Group's biggest Q2 2022 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $2.74M.
- Prostatis Group fully exited Vanguard Growth ETF in Q2 2022, selling an estimated $16.1M.
- Prostatis Group's ten largest holdings make up 82% of its $64.2M portfolio in Q2 2022.
- Prostatis Group opened 7 new positions and closed 44 in Q2 2022.
- Prostatis Group's portfolio value fell 49% quarter-over-quarter to $64.2M.
Based on Prostatis Group's 13F filing for Q2 2022, filed 23 Mar 2023.